Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KAT2B | Q92831 | 2/20 | 0.50 |
| ▸ | PPARD | Q03181 | 1/20 | 0.46 |
| ▸ | PPARA | Q07869 | 1/20 | 0.46 |
| ▸ | FFAR1 | O14842 | 9/20 | 0.44 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.42 |
| ▸ | PLA2G4A | P47712 | 1/20 | 0.40 |
| ▸ | ITGB3 | P05106 | 1/20 | 0.40 |
| ▸ | ITGA2B | P08514 | 1/20 | 0.40 |
| ▸ | TBXAS1 | P24557 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21814457 | 0.81 | KAT2B (0.48) | KAT2B | |
| SCHEMBL21887490 | 0.77 | KAT2B (0.56) | KAT2BCA1CA2 | |
| SCHEMBL21886773 | 0.77 | PPARD (0.46) | KAT2BPPARDPPARAFFAR1KEAP1 | |
| SCHEMBL11193393 | 0.74 | KAT2B (0.60) | KAT2BCA1 | |
| SCHEMBL12632651 | 0.72 | KAT2B (0.61) | KAT2BCA1 | |
| SCHEMBL21814475 | 0.71 | TDP1 (0.52) | KAT2B | |
| SCHEMBL69746 | 0.70 | FFAR1 (0.81) | FFAR1KEAP1CA1CA2 | |
| SCHEMBL349314 | 0.69 | FFAR1 (0.71) | FFAR1KEAP1CA1CA2 | |
| Hydrochloric Acid SCHEMBL25264643 | 0.68 | FFAR1 (0.77) | FFAR1KEAP1TBXAS1CA1CA2 | |
| SCHEMBL1823484 | 0.67 | PPARD (0.62) | PPARDPPARAFFAR1KEAP1ITGB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2020065408-A1 | SULFOMALEIMIDE-BASED LINKERS AND CORRESPONDING CONJUGATES | PIERRE FABRE MEDICAMENT (FR) | 2020-04-02 | — | — | WO | disclosed |